Browse

Legal agreements that directly shape access to care remain invisible to the very people whose lives they govern.

The thinking about what risk Covid poses — or doesn't pose — has shifted in recent years. What does it mean for you?

Indian drug giant Sun Pharma has lined up an $11.75 billion acquisition of Organon, a women’s health and biosimilar maker spun out of Merck in 2021. The all-cash deal came in at $14 per share ...